Peptides
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (3)
- (2)
- (2)
- (1)
- (1)
- (2)
- (3)
- (2)
- (2)
- (1)
- (7)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (4)
- (1)
- (2)
- (2)
- (9)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (4)
- (5)
- (3)
- (3)
- (2)
- (3)
- (1)
- (1)
- (3)
- (8)
- (2)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (2)
- (4)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (3)
- (2)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (1)
- (5)
- (3)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (2)
- (2)
- (6)
- (1)
- (2)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (4)
- (1)
- (2)
- (1)
- (2)
- (6)
- (2)
- (3)
- (1)
- (1)
- (1)
- (1)
- (5)
- (1)
- (3)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (3)
- (3)
- (1)
- (3)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (3)
- (2)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (2)
- (2)
- (2)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (3)
- (2)
- (3)
- (2)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (3)
- (2)
- (1)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (2)
- (3)
- (1)
- (3)
- (4)
- (3)
- (1)
- (1)
- (3)
- (1)
- (1)
- (3)
- (3)
- (2)
- (1)
- (3)
- (2)
- (5)
- (1)
- (1)
- (1)
- (3)
- (2)
- (1)
- (3)
- (1)
- (1)
- (3)
- (2)
- (7)
- (2)
- (2)
- (3)
- (2)
- (2)
- (1)
- (4)
- (5)
- (3)
- (2)
- (2)
- (1)
- (1)
- (1)
- (5)
- (1)
- (1)
- (3)
- (2)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (4)
- (1)
- (2)
- (3)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (2)
- (1)
- (6)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (5)
- (1)
- (3)
- (1)
- (5)
- (4)
- (1)
- (2)
- (1)
- (2)
- (1)
- (2)
- (1)
- (4)
- (4)
- (2)
- (2)
- (2)
- (2)
- (3)
- (1)
- (3)
- (4)
- (4)
- (4)
- (3)
- (2)
- (2)
- (1)
- (2)
- (4)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (6)
- (2)
- (1)
- (3)
- (5)
- (1)
- (8)
- (4)
- (1)
- (1)
- (1)
- (3)
- (1)
- (1)
- (3)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (2)
- (1)
- (2)
- (1)
- (2)
- (1)
- (2)
- (1)
- (5)
- (2)
- (1)
- (1)
- (1)
- (2)
- (1)
- (3)
- (1)
- (3)
- (2)
- (1)
- (2)
- (1)
- (3)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (2)
- (21)
- (13)
- (10)
- (4)
- (5)
- (1)
- (2)
- (15)
- (3)
- (4)
- (1)
- (2)
- (2)
- (2)
- (21,917)
- (13)
- (1)
- (714)
- (1)
- (9)
- (664)
- (5)
- (48)
- (2)
- (2)
- (378)
- (5)
- (4)
- (4)
- (9)
- (54)
- (3)
- (3)
- (3)
- (60)
- (7)
- (1)
- (4)
- (2)
- (5)
- (20,287)
- (111)
- (1)
- (1)
- (287)
- (17)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
Filtered Search Results
R&D Systems™ Melanotransferrin/CD228/MFI2 Recombinant Protein Antigen
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
R&D Systems™ VDP p115 Recombinant Protein Antigen
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
R&D Systems™ LRRC35 Recombinant Protein Antigen
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
R&D Systems™ MYH Recombinant Protein Antigen
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
R&D Systems™ YB1 Recombinant Protein Antigen
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
| Accession Number | Q9NPJ3 |
|---|---|
| Regulatory Status | RUO |
| Purification Method | purified |
| Gene Alias | 0610006O17Rik; Acot13; Acyl-CoA thioesterase 13; acyl-coenzyme A thioesterase 13; Acyl-coenzyme A thioesterase 13, N-terminally processed; HT012; hypothalamus protein HT012; PNAS-27; Them2; thioesterase superfamily member 2 |
| Format | Liquid |
| Preservative | Sodium azide |
| Product Type | Peptide |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Common Name | THEM2 |
| Gene Symbol | ACOT13 |
| Concentration | 200 μg/mL |
| Species | Human |
| Lyophilized | No |
| Accession Number | P39687 |
|---|---|
| Regulatory Status | RUO |
| Purification Method | purified |
| Gene Alias | 2810018A15Rik; Acid nuclear phosphoprotein 32 (leucine rich); acidic (leucine-rich) nuclear phosphoprotein 32 family, member A; acidic (leucine-rich) nuclear phosphoprotein 32 family, member E; acidic leucine-rich nuclear phosphoprotein 32 family member A; Acidic leucine-rich nuclear phosphoprotein 32 family member E; Acidic leucine-rich nuclear phosphoprotein 32 family member E-like protein; acidic nuclear phosphoprotein 32; acidic nuclear phosphoprotein 32 family member A; acidic nuclear phosphoprotein 32 family member E; acidic nuclear phosphoprotein 32 family, member A; acidic nuclear phosphoprotein pp32; AI047746; AI326868; Anp32; Anp32a; Anp32e; C15orf1; cerebellar leucine rich acidic nuclear protein; cerebellar postnatal development protein 1; Cpd1; hepatopoietin Cn; HPPCn; I1PP2A; inhibitor-1 of protein phosphatase-2A; LANP; LANPL; LANP-L; LANP-like protein; Leucine-rich acidic nuclear protein; leucine-rich acidic nuclear protein LANP; leucine-rich acidic nuclear protein like; MAPM; Mapmodulin; mLANP-L; PHAP1; PHAPI; Potent heat-stable protein phosphatase 2A inhibitor I1PP2A; pp32; Putative HLA-DR-associated protein I; putative human HLA class II associated protein I; RP4-790G17.1; vacidic (leucine-rich) nuclear phosphoprotein 32 family, member A; W91701; wu:fb22e03; wu:fc04c12; wu:fc19a08; wu:fc79f04; wu:fi39c10; zgc:65995; zgc:85827 |
| Format | Liquid |
| Preservative | Sodium azide |
| Product Type | Peptide |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Common Name | PHAP III |
| Gene Symbol | ANP32A |
| Concentration | 200 μg/mL |
| Species | Human |
| Lyophilized | No |
R&D Systems™ CCDC14 Recombinant Protein Antigen
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
| Accession Number | O14813 |
|---|---|
| Regulatory Status | RUO |
| Purification Method | purified |
| Gene Alias | aristaless homeobox gene homolog; aristaless homeobox homolog; aristaless homeobox protein homolog; ARIX; arix homeodomain protein; ARIX1 homeodomain protein; CFEOM2; FEOM2; NCAM2; paired like homeobox 2a; paired mesoderm homeobox 2a; paired mesoderm homeobox protein 2A; Paired-like homeobox 2A; Phox2; PHOX2A; PHOX2A homeodomain protein; Pmx2; Pmx2a |
| Format | Liquid |
| Preservative | Sodium azide |
| Product Type | Peptide |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Common Name | PHOX2A |
| Gene Symbol | PHOX2A |
| Concentration | 200 μg/mL |
| Species | Human |
| Lyophilized | No |
| Accession Number | Q96A25 |
|---|---|
| Regulatory Status | RUO |
| Purification Method | purified |
| Gene Alias | 0610008L10Rik; AI043106; BC022145; TMEM106A; Transmembrane protein 106A |
| Format | Liquid |
| Preservative | Sodium azide |
| Product Type | Peptide |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Common Name | TMEM106A |
| Gene Symbol | TMEM106A |
| Concentration | 200 μg/mL |
| Species | Human |
| Lyophilized | No |
R&D Systems™ XAB1 Recombinant Protein Antigen
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
R&D Systems™ L3MBTL4 Recombinant Protein Antigen
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
| Accession Number | P13500 |
|---|---|
| Regulatory Status | RUO |
| Purification Method | purified |
| Gene Alias | Acidic seminal fluid protein; AI323594; C-C motif chemokine 2; C-C motif chemokine ligand 2; Ccl2; chemokine (C-C motif) ligand 2; GDCF-2; HC11; H-MCP-1; HSMCR30; immediate-early serum-responsive JE protein; immediate-early serum-responsive protein JE; Je; MCAF; Mcp1; MCP-1; MCP1A; MCP-1A; MGC9434; Monocyte chemoattractant protein 1; monocyte chemoattractant protein-1; monocyte chemotactic and activating factor; Monocyte chemotactic protein 1; monocyte chemotactic protein 1A; Monocyte secretory protein JE; monocyte-chemoattractant protein-1 precursor; platelet-derived growth factor-inducible protein JE; RP23-350G1.3; SCYA2; Sigje; small inducible cytokine A2; small inducible cytokine A2 (monocyte chemotactic protein 1, homologous to mouse Sig-je); small inducible cytokine subfamily A (Cys-Cys), member 2; small inducible gene JE; small-inducible cytokine A2; SMC-CF |
| Format | Liquid |
| Preservative | Sodium azide |
| Product Type | Peptide |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Common Name | CCL2 (MCP-1) |
| Gene Symbol | Ccl2 |
| Concentration | 200 μg/mL |
| Species | Human |
| Lyophilized | No |
R&D Systems™ MS4A13 Recombinant Protein Antigen
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
R&D Systems™ ABCF1 Recombinant Protein Antigen
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition